[Federal Register Volume 68, Number 26 (Friday, February 7, 2003)]
[Notices]
[Page 6514]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-3051]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated August 20, 2002, and published in the Federal 
Register on October 18, 2002, (67 FR 64419), Research Triangle 
Institute, Kenneth H. Davis, Jr., Hermann Building, East Institute 
Drive, PO Box 12194, Research Triangle Park, North Carolina 27709, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)............................  I
Cocaine (9041)..............................  II
------------------------------------------------------------------------

    The Institute will manufacture small quantities of cocaine 
derivatives and marihuana derivatives for use by their customers 
primarily in analytical kits, reagents and standards. No comments or 
objections have been received. DEA has considered the factors in Title 
21, United States Code, section 823(a) and determined that the 
registration of Research Triangle Institute to manufacture the listed 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Research Triangle Institute on a regular 
basis to ensure that the company's continued registration is consistent 
with the public interest. These investigations have included inspection 
and testing of the company's physical security systems, audits of the 
company's records, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the 
Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.

    Dated: January 27, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-3051 Filed 2-6-03; 8:45 am]
BILLING CODE 4410-09-M